Press ReleasesUrica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States June 29, 2023
Press ReleasesUrica Therapeutics Appoints Seasoned Biotech Executive Jay D. Kranzler, M.D., Ph.D., as Chairman and Chief Executive Officer October 3, 2022
Press ReleasesFortress Biotech Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating dotinurad for the Treatment of Gout in the United States May 31, 2022
Press ReleasesFortress Biotech Announces Exclusive License Agreement With Fuji Yakuhin to Develop dotinurad in North America and Europe May 10, 2021
